Start Date:9/20/2023
Start Time:10:00 AM EDT
Duration:120 minutes
About the event:
Join us for a virtual KOL event with STRATA Skin Sciences, featuring Michael Nazareth, MD, PhD, Iltefat Hamzavi, MD, Ashish Bhatia, MD and Joel Cohen, MD who will discuss STRATA’s XTRAC® and TheraClear®X devices, their mechanism of action, how STRATA’s devices fit into the current treatment landscape, and how practices are effectively integrating the devices into their service offerings. STRATA’s CEO, Bob Moccia, will also provide a business update addressing the company’s current and future growth plans.
A live question and answer session will follow the formal presentations.
ABOUT STRATA SKIN SCIENCES: STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing and marketing innovative products for the in-office treatment of various dermatologic conditions such as psoriasis, vitiligo, and acne. Its products include the XTRAC® excimer laser, VTRAC® lamp systems, and the TheraClear®X Acne Therapy System.
If you're already registered for the STRATA Skin Sciences KOL Webinar on XTRAC® and TheraClear®X webcast, click below:
ALREADY REGISTERED?
Speakers
 Bob Moccia Chief Executive Officer STRATA Skin Sciences Robert “Bob” Moccia assumed the duties of Chief Executive Officer and member of the Board on March 1, 2021. Mr. Moccia has more than 20 years of executive management experience as President, COO, and CEO of small to mid-sized specialty pharmaceutical companies and over 35 years of global pharmaceutical experience with expertise in general management, operations, strategic planning, business development, product development, sales, marketing, and building customer focused organizations. Most recently, Mr. Moccia co-founded Encore Dermatology. Prior to founding Encore, Mr. Moccia was CEO of Precision Dermatology Inc., which was sold to Valeant in 2014. Mr. Moccia has marketed and/or launched over 30 dermatological products in the US and created over $1.2B in exit transactions. He has completed multiple licenses, acquisitions and partnerships in the dermatology space. Mr. Moccia has held executive management positions at Medicis Pharmaceuticals (Sr. VP of Corporate Development), Graceway Pharmaceuticals (President & COO), and Bioglan Pharmaceuticals (President). He also spent time at Dermik and Stiefel Laboratories in sales, marketing, and business development. Mr. Moccia holds a B.S. in Biology from Stonehill College.
 Rich Cockrell - Moderator President and Founder of CG Capital CG Capital Rich Cockrell has a combined 20+ years experience in investor relations and as a Wall Street analyst. He has managed Strategic Finance, Financial Planning & Analysis and Investor Relations activities at Fortune 100 and 1000 companies such as Kinetic Concepts (KCI), The Home Depot Inc., El Paso Corp., ING Americas and Motorola. It was early in his career, while an Equity Analyst with UBS, when Rich first discovered his gift for investor relations. His broad experience spans a multitude of key industries and encompasses publicly-traded, pre-IPO, high growth, under-valued and liquidity-challenged companies.
 Michael Nazareth, M.D., Ph.D. President of Western New York Dermatology Western New York Dermatology Michael Nazareth is the president of Western New York Dermatology and a board certified dermatologist. He was born and raised in Buffalo and attended St. Joe’s Collegiate Institute for High School. He earned a BS in biology at Canisius College and then went on to the State University of New York at Buffalo School of Medicine and Biomedical Sciences, where he earned his MD and PhD degrees. He then completed a dermatology residency at SUNY Buffalo, during which time he trained at Roswell Park Cancer Institute, Women and Children’s Hospital of Buffalo, Buffalo General Medical Center and the Veterans Administration Hospital. He was chief resident in the final year of his residency training. Dr. Nazareth is a member of the American Academy of Dermatology, the Society for Pediatric Dermatology, the American Society for Dermatologic Surgery, the American Medical Association and the Medical Society of the State of New York. Dr. Nazareth looks forward to working closely with patients of all ages to meet their complete dermatologic needs by offering a comprehensive range of medical, surgical, and cosmetic treatments.
 Iltefat Hamzavi, M.D. Owner of Hamzavi Dermatology Hamzavi Dermatology Dr. Iltefat Hamzavi, M.D., has practiced at Hamzavi Dermatology Specialist offices since 2001 and sees general dermatology with a special focus on pigmentary disorders and hidradenitis suppurativa. He earned his Bachelor of Arts degree, with honors, in Sociology from the University of Michigan, Ann Arbor. Dr. Hamzavi received his medical degree from the University of Michigan Medical School and graduated with academic honors in a variety of specialty rotations. He completed his residency in dermatology at Wayne State University and then spent time in Europe training at some of the world’s leading skin care centers. In 2001, he completed an advanced one-year laser and photo-medicine fellowship at the University of British Columbia in Vancouver. Dr. Hamzavi is an active clinic researcher and investigates causes and treatments for vitiligo, hidradenitis suppurativa, photomedicine, and other conditions. He also serves as senior staff physician at Henry Ford Health System Department of Dermatology, and teaches medical students at Wayne State University. He has co-authored over 300 peer reviewed papers which have been cited over 12000 times in highly respected journals. He also volunteers his time with a variety of non-profits in education, civic engagement and bringing attention to debilitating skin diseases, and has served as founding Co-Chair of the Global Vitiligo Foundation, board member at the Photodermatology society and as President of the Hidradenitis Suppurativa Foundation.
 Ashish Bhatia, M.D. (FAAD) Board-Certified Dermatologist and Mohs Surgeon at Oak Dermatology Oak Dermatology Dr. Ashish Bhatia is a board-certified and fellowship-trained dermatologist and dermatologic surgeon. He is an internationally recognized expert in dermatologic surgery and cosmetic surgery. His expertise includes facial and body aesthetic surgery, skin cancer therapy, Mohs and reconstructive surgery, laser surgery, and skin resurfacing procedures, including scar reduction and revision. Dr. Bhatia has contributed to the advancement of techniques in facial reconstruction, scar revision, fat reduction, and the use of purified neurotoxins and fillers. He has helped bring over 25 drugs and devices to market, including the development of 2 acne devices.
He has published extensively in journals and textbooks and is a sought-after teacher, speaker, and instructor both nationally and internationally. Through his clinical research, publications, public service initiatives, and the use of innovative technologies for instruction, Dr. Bhatia has made a broad range of intellectual and practical contributions to the fields of dermatology and dermatologic surgery.
Dr. Bhatia received his medical degree from Northeastern Ohio University College of Medicine where he was inducted into the Alpha Omega Alpha national medical honors society and earned awards for both achievement and service. He completed his residency in dermatology at the Medical College of Virginia Hospitals where he served as chief resident. Subsequently, he completed an intensive fellowship in Mohs surgery, cutaneous oncology, reconstruction, cosmetic, and laser surgery at SkinCare Physicians in Boston, MA under the direction of leaders in the field from Boston University, Harvard University, and Yale University School of Medicine.
Dr. Bhatia is an associate professor of clinical dermatology at Northwestern University, Feinberg School of Medicine. He previously served as the chairman of the department of dermatology at DuPage Medical Group. Dr. Bhatia's memberships include the American Academy of Dermatology, the American Society for Dermatologic Surgery, the American Society for Laser Medicine and Surgery, the American College of Mohs Surgery, and the American Medical Association.
 Joel Cohen, M.D. (FAAD, FACMS) Director of AboutSkin Dermatology and DermSurgery AboutSkin Dermatology & DermSurgery, PC Joel L. Cohen, MD (FAAD, FACMS) is an internationally-recognized expert on aesthetics and skin cancer. He is the Director of AboutSkin Dermatology and DermSurgery, and AboutSkin Research in metropolitan-Denver, Colorado. He was named a Top Dermatologist by US News and World Report, Castle Connelly Top Doctor (2013-2023), and voted by his peers as one of Denver's Top Doctors in 5280 magazine 10-times. He is a Board-Certified Dermatologist, and Fellowship-trained in Mohs Surgery, Lasers and Cosmetic Dermatology.
Dr. Cohen has published over 294 medical articles and book chapters, and has co-authored 3 academic textbooks. He lectures every month at national meetings as well as at many international congresses, and has participated in over 100 clinical trials including key aesthetic lasers and devices. He is on the teaching faculty of the University of California Irvine as an Associate Professor of Dermatology. Dr. Cohen has received many prestigious awards including the Melanoma Research Foundation Humanitarian of the Year Award, the ASDS Public Service Award, the ASDS Patient Safety Hero Award, the ASDS Excellence in Education Award, the ASCDAS Distinguished Service Award, and the ASDS Traveling Mentorship & Teaching Award.
He has been quoted in many newspapers & magazines including: Vogue, TIME, Glamour, Elle, Allure, The New York Times (x4), Reader’s Digest, Shape, USA Today, US News & World Report, InStyle, BuzzFeed, MSN.com, ABC.com, NewBeauty, Condé Nast, Men’s Health, Huffington Post, International Business Times, Consumer Reports (x8), SELF, Women’s Health and MORE Magazine.
He regularly appears on Denver TV stations (with over 75 appearances discussing aesthetic issues, dermatology, and skin cancer), and has been a guest on many segments of SiriusXM Doctor Radio. He was also featured on the Emmy Award winning show “The Doctors.”
|
|
|